84,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
42 °P sammeln
  • Broschiertes Buch

This book addresses the neurobiology, pharmacotherapy, and behavioural therapy of substance use disorders from a clinical perspective. Ideal for residents and fellows, this book will provide a solid background for learning in psychiatry and addiction medicine and can also be used in clinical practice.

Produktbeschreibung
This book addresses the neurobiology, pharmacotherapy, and behavioural therapy of substance use disorders from a clinical perspective. Ideal for residents and fellows, this book will provide a solid background for learning in psychiatry and addiction medicine and can also be used in clinical practice.
Autorenporträt
F. Gerard "Gerry" Moeller, MD, is Director of the C. Kenneth and Dianne Wright Center for Clinical and Translational Research, and Associate Vice President for Clinical Research at Virginia Commonwealth University. He is also Director of the Institute for Drug and Alcohol Studies and Division Chair for Addiction Psychiatry. Awarded the C. Kenneth and Dianne Wright Distinguished Chair in Addiction Science, his research focuses on translational research on addictions, with a goal of developing novel treatments that reduce drug use and overdose. He is board certified in Psychiatry and Addiction Medicine. Mishka Terplan, MD, MPH, is board certified in both obstetrics and gynecology and in addiction medicine. His primary clinical, research, and advocacy interests lie along the intersections of reproductive and behavioral health. He is Associate Medical Director at Friends Research Institute and adjunct faculty at the University of California, San Francisco where he is a Substance Use Warmline clinician for the National Clinical Consultation Center. He is also the Addiction Medicine Specialist for Virginia Medicaid and a consultant for the National Center on Substance Abuse and Child Welfare. Dr. Terplan has active has published over 100 peer-reviewed articles with emphasis on health disparities, stigma, and access to treatment.